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Abstract
We compared intima–media thickness (IMT) and the prevalence of plaques in the common carotid artery (CCA) and common
femoral artery (CFA) in apparently healthy participants. This multicenter study included 322 participants (59.9% female; age
20-78 years, mean 52.1 + 15.3 years) who underwent Echo-color Doppler examination of the CCA and CFA bilaterally. Pre-
valence and composition of plaque were recorded. A significant (P < .01) difference between mean CCA-IMT and mean CFA-IMT
was detected (0.70 vs 0.73 mm). Plaque prevalence was significantly higher in the CFA compared to the CCA (40.7% vs 30.4%).
Atherosclerotic plaques were found in both CFA and CCA in 46% of the cases, solely in CFA in 38%, and in CCA alone in 17%.
The observed difference in plaque prevalence was even greater when only fibrolipid isolated plaques were considered (CFA 39.4%
vs CCA 22.1%). In a healthy general population, atherosclerotic plaques were present in the CFA but not in the CCA in over one-
third of the cases. Further studies must confirm whether ultrasonography of the CFA might be introduced in the screening
protocols for cardiovascular risk assessment.
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Introduction
Atherosclerosis and consequent cardiovascular (CV) disease
(CVD) represent the main cause of death in Europe, with wide
differences in mortality rates between different countries.1 In
Italy, morbidity and mortality rates due to atherosclerotic dis-
ease remain high, despite the adoption of major prevention
strategies, such as campaigns against smoking and excessive
alcohol consumption, promotion of maintenance of healthy
body weight, and participation in physical activity.2
Since major CV risk factors and the deriving risk equations
are able to predict a substantial but limited proportion of CV
events, the assessment of early vascular changes has gained
increasing popularity in both prevention and clinical settings
as a tool to improve CV risk stratification beyond traditional
risk factors.3-6 In addition to coronary arteries, carotid and
lower extremity arteries are 2 districts where atherosclerotic
lesions commonly occur. Carotid atherosclerotic lesions are
regarded as an indicator of generalized atherosclerosis, and
carotid intima–media thickness (IMT) is an established inde-
pendent predictor of stroke and CVD.7,8 The American College
of Cardiology and American Heart Association guidelines on
the assessment of CV risk gave a class IIa recommendation for
carotid IMT ultrasound assessment in asymptomatic adults at
intermediate risk of CVD.9 Moreover, carotid IMT has been
1Department of Radiology, Oncology and Anatomic Pathology, Vascular and
Interventional Radiology Unit, Policlinico Umberto I, ‘‘Sapienza’’ University of
Rome, Rome, Italy
2Genetic Epidemiology Unit, National Centre of Epidemiology, Surveillance
and Health Promotion, Istituto Superiore di Sanita`, Rome, Italy
3Department of Radiology and Oncotherapy, Semmelweis University, Buda-
pest, Hungary
4 Vascular and Endovascular Surgery Division, Department of Surgery ‘‘Paride
Stefanini’’, Policlinico Umberto I, ‘‘Sapienza’’ University of Rome, Italy
5 Unita` di Medicina Interna, Universita` di Perugia, Ospedale ‘S. Maria’, Terni,
Italy
6Department of Neurosciences, University of Padua School of Medicine,
Padua, Italy
Corresponding Author:
Pierleone Lucatelli, Department of Radiology, Oncology and Anatomic
Pathology, Vascular and Interventional Radiology Unit, Policlinico Umberto I,
‘‘Sapienza’’ University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
Email: pierleone.lucatelli@gmail.com
Angiology
2017, Vol. 68(3) 257-265
ª The Author(s) 2016
Reprints and permission:
sagepub.com/journalsPermissions.nav
DOI: 10.1177/0003319716651777
journals.sagepub.com/home/ang
proven to correlate with future CV events10 and in individuals
undergoing revascularization procedures.11
The distance between lumen–intima and media–adventitia
interfaces of peripheral arteries (carotid and femoral arteries)
can be measured noninvasively by B-mode ultrasound. The pres-
ence and characterization of atherosclerotic plaques and the
degree of stenosis can also be assessed.12 Evaluation of the mean
IMT of the peripheral large arteries is inexpensive, widely avail-
able, and easily reproducible.13 In comparison with the carotid
artery plaques, the association between femoral artery athero-
sclerosis and CVD has received less attention to date. Recently,
femoral ultrasound examination has been shown to correlate
with subclinical atherosclerosis,14 to be associated with coronary
artery calcium score (CACS),15 and to be an independent pre-
dictor of future CV events.16-20 For all, there is a growing interest
on femoral ultrasound as an adjunctive tool to carotid examina-
tion for CV risk stratification, but no guidelines persist in recom-
mending the use of femoral ultrasound as a screening tool.21
The aim of our multicenter study was to compare the mean
carotid and femoral arteries IMT and the prevalence of athero-
sclerotic plaques in both territories in a sample of apparently
healthy participants.
Materials and Methods
Study Population
This study is part of a large follow-up international twin
study22 conducted in Italy, Hungary, and United States to
evaluate the role of genetic and environmental factors on
atherosclerotic traits.23-25
Twins, previously enrolled in the Italian Twin Registry
(ITR),26 were invited by mail/e-mail to participate in the study.
Participants older than 18 years and residents in Rome, Padua,
Perugia, and Terni or their outskirts were invited to participate.
None of the enrolled patients had a history of carotid surgery or
pregnancy. A total of 322 healthy participants were recruited
between March and December 2014 at the university hospitals
located in the city of residence. All enrolled participants signed a
written informed consent to participate in the study. Approval
for the study was granted by the university ethics review board,
and the study was performed conform to the declaration of Hel-
sinki. All participants were assessed for the presence of CV risk
factors, such as hypertension, diabetes, and smoking habits.27,28
Measurements
The entire measurement protocol was standardized among the 4
recruitment centers to avoid any potential intercenter bias. The
same sonographer (A.D.T.) performed the measurements in Per-
ugia, Terni, and Padua, whereas another sonographer (P.L.) per-
formed the same protocol in Rome after careful training by ADT.
General risk factors assessment. Systolic blood pressure and
diastolic blood pressure, mean arterial pressure (MAP), and
heart rate were measured by TensioMed Arteriograph
(Medexpert Ltd, Budapest, Hungary) on the dominant arm,
with the participant lying in supine position after 10 minutes
of rest. Height and weight were measured by OMRON BF500
device to calculate body mass index (BMI; kg/m2). Relevant
medical history and pharmacological treatment were self-
reported by the participants. Participants were asked to fill
in several extended questionnaires regarding sociodemo-
graphic characteristics, risk factors, and personal habits
(smoking and physical activity).
Carotid and femoral arteries ultrasound protocol. All participants
underwent peripheral arterial assessment by B-mode ultra-
sound using state-of-the-art commercially available high-
resolution color-coded duplex sonography scanners (MyLab70,
Esaote, Genova, Italy, Rome; Sonoscape S8, Perugia; Toshiba
Aplio XG, Padua, Italy; Esaote MyLab60 in Terni, Italy), with
high-frequency (12 MHz) linear probes.
The following vascular sites were examined in all
participants:
 Supra-aortic vessels: Carotid arteries were examined
bilaterally in both axial and transversal planes from the
supraclavicular fossa to the submandibular angle,
including common carotid artery (CCA), carotid bulb,
and origin of both internal and external carotid arteries
(ICA and ECA).
 Femoral district: the common femoral arteries (CFAs)
were examined bilaterally, from their point of entry into
the Scarpa triangle till the bifurcation in superficial and
deep femoral arteries (SFA and DFA). The SFA was
then examined from its origin till its point of entry into
the Hunter canal, where it deepens and consequently
IMT thickening or plaque identification and character-
ization are impaired.
Intima–media thickness and plaque were defined according
to the Mannheim consensus.29 In particular, IMT is defined as
the distance from the leading edge of the lumen–intima inter-
face to the leading edge of the media–adventitia interface.
Intima–media thickness was measured on each investigated
arterial segment online using calipers. To improve accuracy,
at least 3 IMT measurements were taken in each segment and
were averaged. In case of plaque presence, IMT value was
measured in the adjacent plaque-free segment.
Atherosclerotic plaque was defined as an endoluminal pro-
trusion of at least 1.5 mm or a >50% focal thickening of the
IMT relative to the adjacent wall segment.30 Plaque presence
and its size on both transverse and longitudinal planes were
recorded in each segment. Moreover, all observed plaques were
classified according to their morphological characteristics/
compositions31,32 as:
 calcified if the plaque presented as hyperechogenic with
echogenic shadow in its entire extension;
 fibrolipid (soft) if the plaque presented a hypoechogenic
appearance in its entire extension; and
 mixed a combination of previous 2 types.
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All the involved sonographers were specifically and care-
fully trained at the beginning of the study on all the different
aspects of the shared screening protocol in order to reduce the
potential bias of the 2 different operators.
Statistical Analysis
Descriptive analysis for investigated characteristics, including
mean and standard deviation for continuous variables and per-
centage for categorical variables, was performed.
For the purpose of the study, Italian twin participants were
analyzed as individuals rather than twin pairs, and statistical
comparisons were performed within participants. Mean IMT in
CCA (IMT CCA) and in CFA (IMT CFA) were calculated as
the mean of IMT in right and left side for both segments.
Moreover, intraindividual differences between mean IMT CFA
and mean IMT CCA were calculated, and the mean of the
differences was also estimated (Mean diff ¼ mean IMT CFA
 mean IMT CCA).
Carotid and femoral plaque was defined as the presence of at
least 1 atherosclerotic plaque in any of the examined sections on
the right and left side (internal, external, and common in carotid
artery; superficial, deep, and common in femoral arteries).
Student t test for paired data was used to compare mean IMT
values calculated in carotid and femoral arteries, and McNemar
test was performed for comparison of plaque prevalence
between the 2 arterial segments. Paired test is a powerful way
to isolate the effect of the factor of interest from the effects of 1
or more variables possibly playing a role. In our sample, this
approach allowed us to control for potentially confounding vari-
ables such as age, MAP, gender, clinical history, and drugs use.
We performed these analyses on the overall data set as well
as on subsets of the data defined according to the presence of
atherosclerotic risk factors. Moreover, plaque analysis was first
carried out using the total sample and then replicated on a
restricted sample characterized by the presence of only fibro-
lipid/mixed atherosclerotic plaques. Chi-square for trend test
was used to test for linear trend across groups of age.
Twins were treated as independent observations in all anal-
yses. In order to explore possible clustering effects, the analy-
ses were also conducted using independent twins randomly
selected 1 from each pair, and results were compared between
the 2 approaches. All analyses were performed using Stata
Software(version 11.2, StataCorp, College Station, Texas).
Results
The study population consisted of 322 participants: 129
(40.1%) participants were male and mean age at enrollment
was 52.1 years (range 20-78 years). Demographic and clinical
characteristics of the participants are shown in Table 1.
Intima–Media Thickness
As reported in Table 2, mean IMT was 0.70 mm in the CCA
and 0.73 mm in the CFA (P ¼ .0016). The earlier difference
was significant in men (mean 0.05 mm, P ¼ .0008) but not in
women (mean 0.02 mm, P¼ .17). Figure 1 shows mean carotid
and femoral IMT distribution by age. As expected, IMT
increased with age for both segments. Participants older than
41 years showed higher IMT values in the CFA compared to
the CCA, while there were no differences between IMT CCA
and IMT CFA values in participants younger than 40 years
(mean IMT 0.531 mm and 0.532 mm, respectively). Moreover,
the means of intraparticipant differences (Mean diff ¼ IMT
CFA  IMT CCA) were significantly different from 0 in the
last 2 classes of age, 41 to 55 and 56 years.
Finally, participants were stratified by 4 atherosclerotic risk
factors (hypercholesterolemia, present/absent; smoke habits,
never smokers/ex or current smokers; BMI, normal weight/
overweight or obese; MAP, above or below the median value
detected in our sample, 90) and differences compared. Results
were statistically significant for each comparison, except for
BMI (Table 2).
Plaque Prevalence
About one-third (30.4%) of the sample had at least 1 plaque in
the carotid artery (Table 2), whereas prevalence of plaques in
CFAs was about 40% (McNemar test, P ¼ .0003).
Table 1. Demographic and Clinical Participants Characteristics.
n
Overall Sample, %
or Mean+ SD
Age, years 322 52.1 + 15.3
Gender, Male 129 40.06%
BMI, kg/m2 322 25.50 + 4.27
MAP, mm Hg 319 90.9 + 12.9
Heart rate, /min 319 67 + 10
Hypertension 67 21.27%
Diabetes 13 4.10%
Hypercholesterolemia 62 19.87%
Physical activity
Moderate/vigorous 195 60.56%
Smoking habits
Never-ex smoker 236 74.22%
Current smoker 82 25.79%
IMT
Left common carotid IMT, mm 322 0.72 + 0.22
Right common carotid IMT, mm 321 0.68 + 0.20
Left common femoral IMT, mm 322 0.72 + 0.25
Right common femoral IMT, mm 321 0.73 + 0.26
Prevalence of Plaques
Carotid plaque, left side 39 12.11%
Carotid plaque, right side 31 9.63%
Femoral plaque, left side 103 31.99%
Femoral plaque, right side 87 27.02%
Plaque composition
Carotid plaque composition
Calcified 21 21.43%
Fibrolipid or mixed 77 78.57%
Femoral Plaque composition
Calcified 32 24.43%
Fibrolipid or mixed 99 75.57%
Abbreviations: SD, standard deviation; BMI, body mass index; MAP, mean
arterial pressure; IMT, intima–media thickness.
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Prevalence of atherosclerotic plaques in both segments
increased significantly by age (Chi square for trend P < .01),
and the femoral site had higher prevalence in all age classes
compared to carotid (CFA 10.5%, 31.0%, and 66.9% vs CCA
2.33%, 18.0%, and 57.4% in 40, 41-55 and 56 years,
respectively). When our data were stratified, as described ear-
lier, for the main risk factors, statistically significant differ-
ences in prevalence of plaques between carotid and femoral
arteries were observed.
Participants were also classified taking into account the
presence/absence and the site of the plaques simultane-
ously. Half of the sample had no plaques and, among par-
ticipants with at least a plaque, 46% had a plaque in both
segments. Prevalence of isolated femoral and carotid
plaques was 38% and 17%, respectively. Distributions are
reported in Figure 2A.
As shown in Table 1, most of the plaques had a fibrolipid or
mixed composition (78.6% in the CCA and 75.6% in the CFA),
and only few individuals showed calcified atherosclerotic pla-
ques (about 20%). When the analysis was restricted to the
participants with fibrolipid or mixed-composition plaques, as
previously detected in the total sample, frequency of isolated
plaques in the CFA (39%) was higher than in the CCA (22%).
The prevalence of fibrolipid or mixed plaque in the CCA and/or
CFA is shown in Figure 2B.
Results changed slightly only when the analyses were
restricted to independent twins selected at random, 1 from each
pair, indicating minor clustering effects. In particular, signifi-
cant differences were detected between carotid and femoral
IMT (paired t test P ¼ .03) as well as between prevalence of
plaques in the 2 arteries (McNemar test, P ¼ .002).
Discussion
Our study demonstrated that mean IMT was significantly
greater in the CFA than in the CCA in our healthy population
(Figures 3 and 4). This difference, though relatively small in
magnitude, needs to be carefully taken into account, as the
reported CCA IMT values are in line with the reference CCA
IMT values elaborated by large cohort studies (30, 32). Mean
CFA IMT was higher in the subgroup of participants older than
41 years. Interestingly an isolated femoral plaque was found in
over one-third of the investigated participants. These results
suggest the hypothesis that early intima–media thickening at
the common femoral site could represent a prompt marker of
subclinical atherosclerosis. Therefore, especially considering
the distribution of CVD by age in the general population33 and
Table 2. Mean Intima–Media Thickness (IMT) Artery and Plaques Prevalence Overall and by Gender or Other Risk Factors.
n
Mean IMT, Common
Carotid Artery, mm n
Mean IMT, Common
Femoral Artery, mm Pa n
Prevalence of
Carotid Plaques n
Prevalence of
Femoral Plaques Pb
Total sample 321 0.70+ 0.20a 321 0.73+ 0.24a .002 98 30.43% 131 40.68% .0003
Gender
Males 128 0.70+ 0.21 128 0.75+ 0.23 .0008 50 38.76% 60 46.51% .10
Females 193 0.71+ 0.24 193 0.69+ 0.19 .17 48 24.87% 71 36.79% .001
Hypercholesterolemia
No 248 0.67+ 0.19 247 0.69+ 0.24 .01 61 24.60% 80 32.26% .01
Yes 66 0.79+ 0.20 67 0.84+ 0.23 .05 33 49.25% 47 70.15% .003
Smoking habits
Never 165 0.67+ 0.20 165 0.70+ 0.22 .07 36 21.82% 55 33.33% .005
Current and ex smoker 152 0.72+ 0.20 152 0.76+ 0.26 .008 58 37.91% 72 47.06% .03
BMI
Normal weight 151 0.62+ 0.17 150 0.64+ 0.23 .15 26 17.22% 44 29.14% .001
Overweight/obese 170 0.76+ 0.20 171 0.80+ 0.23 .004 72 42.11% 87 50.88% .04
MAP, mm Hg
<90 166 0.61+ 0.16 166 0.64+ 0.23 .02 30 17.96% 46 27.54% .004
90 152 0.79+ 0.19 152 0.82+ 0.22 .02 66 43.42% 84 55.26% .01
Abbreviations: BMI, body mass index; MAP, mean arterial pressure.
aPaired t test, IMT carotid artery vs IMT femoral artery.
bMcNemar test, prevalence of carotid plaque versus femoral plaque.
Figure 1. Mean intima–media thickness (IMT) in carotid and femoral
arteries by age.
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the high prevalence of isolated femoral plaques in our sample,
CFA IMT ultrasound assessment might gain a role in the eva-
luation of CV risk if further studies confirm our findings. More
in detail, according to the current guidelines of the American
College of Cardiology and American Heart Association on the
assessment of CV risk, carotid IMT ultrasound assessment
received a class IIa recommendation to be used in asympto-
matic adults at intermediate risk of CVD.9 Based on our results,
the evaluation of CFA could be considered at least as an alter-
native option in the same population. Furthermore, with the
aim to reliably assess the CV risk in patients, the high preva-
lence of isolated femoral plaque suggests that, in a certain
percentage of cases, a subclinical atherosclerotic condition can
be misdiagnosed in patients evaluated for carotid disease only.
Other authors already suggested a major role of CFA ultra-
sound evaluation in the management of CVD. For instance,
Khoury et al demonstrated that atherosclerotic plaques in CFA
represented stronger predictors of disease than in CCA in a
population of 120 patients with suspected coronary artery dis-
ease,34 whereas Schmidt et al proved that CFA plaques can be
predictive of CVD in middle-aged women.35 Our results,
derived from an outpatient asymptomatic population, suggest
the idea that CFA ultrasound evaluation might be, in the near
future, incorporated in the general guidelines for CVD risk
stratification. The advantage of this incorporation may rely
on the identification of a part of population otherwise missed
if these patients are examined with carotid scan only.
Other relevant results of our study concern plaque composi-
tion, since most of the detected plaques had a fibrolipid or
mixed structure. In addition, when analysis was restricted to
participants with fibrolipid or mixed composition plaques, the
frequency of isolated plaques in CFA was clearly higher than in
CCA (39.4% vs 22.1%). Etiopathogenetic considerations arise
from the latter observation, which may suggest at least a slight
difference in the genesis of atherosclerotic plaques in CCA and
CFA.36 This hypothesis is even supported by differences
between the distribution of atherosclerotic plaques in carotid
and femoral sites already highlighted by previous authors. For
example, Bossuyt et al observed a significant right–left differ-
ence in IMT of CFA but not of CCA and suggested a possible
role of local geometry in the development of atherosclerosis37;
however, this side difference has not been observed in our
series. This idea is also strengthened by pathology and bio-
chemical studies: Pathology studies demonstrated that athero-
sclerotic plaques sited in different segments of the arterial tree
have commonalities in cell types, but their relative numbers
and amount of connective tissue and lipids can vary consider-
ably36; biochemical studies proved a different correlation
between circulating lipoprotein and femoral plaques in com-
parison with carotid plaques.38 Twin studies also reported a
heritable component on carotid and femoral IMT, which makes
a heterogeneous contribution to carotid IMT by segment.24,39,40
A potential role of CFA ultrasound evaluation in the general
guidelines for CVD risk stratification has already been men-
tioned. Furthermore, the presented results on plaque prevalence
and composition could have additional clinical impact on the
management of patients with atherosclerosis7,8; for example,
an earlier assessment of atherosclerotic plaques in CFA might
lead to an earlier start of medical treatment (eg, statin therapy)
in these patients. In addition, CFA IMT could be also used to
assess treatment efficacy. Ibrahimi et al demonstrated that sta-
tin therapy is associated with a favorable increase in carotid
plaque echogenicity; based on the high prevalence of fibrolipid
plaques in CFA, we can speculate that the evaluation of CFA
could represent an even better option to assess treatment effects
in the same population.41
When carotid or femoral IMT and plaques prevalence were
compared separately according to atherosclerotic risk factors,
results were statistically significant for each comparison. These
findings suggest that a combined US examination of the 2
districts can improve the detection of lesions in participants
with or without hypercholesterolemia, smoke habit, over-
weight, or higher MAP values.
This study has limitations. One is related to the nonindepen-
dence of twin observations; however, the results of the analyses
conducted on a subgroup of independent twins randomly
selected 1 from each pair were comparable to those obtained
on the total sample, and this suggested minor clustering effects.
Furthermore, different ultrasound machines were used in the
study centers. On the other hand, the strength of the study was
the recruitment of a large population of healthy participants,
whereas in previous studies on patients with atherosclerosis
and femoral ultrasound had past history of CV events or were
Figure 2. Prevalence of plaques in carotid and/or femoral arteries.
All plaque compositions (A) and fibrolipid or mixed composition
plaques (B).
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already scheduled for endovascular treatment.42,43 Moreover,
our within-participants design has important advantages in
terms of power and control of confounding.
In conclusion, our ultrasound study conducted on a general
healthy population has identified more plaques in CFA than in
CCA, with a high prevalence of isolated femoral plaque and
fibrolipid composition. The CFA-IMT was significantly higher
than CCA-IMT. If confirmed by future studies, these results
suggest the potential use of CFA-IMT assessment as an early
biomarker of atherosclerosis and the introduction of femoral
artery ultrasound in the screening protocols for cardiovascular
risk assessment.
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